metronidazole has been researched along with Escherichia coli Infections in 61 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The characteristics and outcomes of patients infected with ESBL-ENT were examined in a pooled analysis of Phase 3 clinical trials of ceftolozane/tazobactam in patients with complicated urinary tract infections (ASPECT-cUTI) and complicated intra-abdominal infections (ASPECT-cIAI)." | 9.24 | Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials. ( Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O, 2017) |
| "The fecal flora obtained from 13 patients with ulcerative colitis was examined at the beginning of a pouchitis episode before treatment, during treatment with metronidazole or ciprofloxacin, and during pouchitis-free periods." | 9.11 | Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. ( Gosselink, MP; Hop, WC; Laman, JD; Ruseler-van Embden, JG; Schouten, WR; van Lieshout, LM, 2004) |
| " The purpose of the present study was to investigate the effects of mesalazine, and metronidazole-gentamicin combination, on bacterial translocation in an animal colitis model." | 7.72 | Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis. ( Aydogan, H; Gulec, B; Kilinc, M; Kozak, O; Ozcan, A; Pekcan, M; Yigit, T; Yigitler, C, 2004) |
| "Metronidazole was used for treatment of 212 patients with peritonitis of appendicular origin." | 7.67 | [Metronidazole in the complex treatment of peritonitis of appendicular etiology in children]. ( Astakhov, AA; Kharchenko, DM; Sleptsov, VP; Slezkin, GA, 1987) |
| "A 69-year-old man developed meningitis due to Bacteroides fragilis and Streptococcus MG-intermedius, which progressed during chloramphenicol and nafcillin therapy to the extent that he seemed near death, with frank pus covering the spinal cord at surgery." | 7.66 | Intravenous metronidazole therapy for Bacteroides fragilis meningitis. ( Bryan, CS; Del Bene, VE; Huffman, LJ; Sanders, CV; Scalcini, MC, 1979) |
| " This study demonstrated the efficacy of penicillin and clavulanic acid in the treatment of infections caused by Bacteroides fragilis alone or in combination with beta-lactamase-producing aerobic bacteria." | 5.27 | Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria. ( Brook, I; Coolbaugh, JC; Walker, RI, 1983) |
| " The characteristics and outcomes of patients infected with ESBL-ENT were examined in a pooled analysis of Phase 3 clinical trials of ceftolozane/tazobactam in patients with complicated urinary tract infections (ASPECT-cUTI) and complicated intra-abdominal infections (ASPECT-cIAI)." | 5.24 | Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials. ( Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O, 2017) |
| "The fecal flora obtained from 13 patients with ulcerative colitis was examined at the beginning of a pouchitis episode before treatment, during treatment with metronidazole or ciprofloxacin, and during pouchitis-free periods." | 5.11 | Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. ( Gosselink, MP; Hop, WC; Laman, JD; Ruseler-van Embden, JG; Schouten, WR; van Lieshout, LM, 2004) |
| " We believe that the association C3G+aminoglycoside+metronidazole should be used first-line in the pediatric peritonitis in our context." | 3.79 | [Bacteriology of community-acquired peritonitis in children treated in the university hospital of Marrakech]. ( Boutbaoucht, M; Chabaa, L; Mouaffak, Y; Oulad Saiad, M; Salama, T; Soraa, N; Younous, S, 2013) |
| "The purpose of this study was to determine if a change in the vaginal flora was associated with an increased risk of preterm birth, and to determine if metronidazole therapy before 32 weeks increased the risk of preterm birth." | 3.73 | Is a change in the vaginal flora associated with an increased risk of preterm birth? ( Carey, JC; Klebanoff, MA, 2005) |
| "After antibiotic prophylaxis with metronidazole and levofloxacin, a transrectal sextant biopsy was performed under the guide of transrectal ultrasonography (TRUS) for a 75-year-old suspicious patient with prostate adenocarcinoma." | 3.73 | Life-threatening meningitis resulting from transrectal prostate biopsy. ( Chen, SW; Shen, ZJ; Wang, H; Zhao, JP; Zhou, XL, 2005) |
| " The purpose of the present study was to investigate the effects of mesalazine, and metronidazole-gentamicin combination, on bacterial translocation in an animal colitis model." | 3.72 | Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis. ( Aydogan, H; Gulec, B; Kilinc, M; Kozak, O; Ozcan, A; Pekcan, M; Yigit, T; Yigitler, C, 2004) |
| "Metronidazole was used for treatment of 212 patients with peritonitis of appendicular origin." | 3.67 | [Metronidazole in the complex treatment of peritonitis of appendicular etiology in children]. ( Astakhov, AA; Kharchenko, DM; Sleptsov, VP; Slezkin, GA, 1987) |
| "A 69-year-old man developed meningitis due to Bacteroides fragilis and Streptococcus MG-intermedius, which progressed during chloramphenicol and nafcillin therapy to the extent that he seemed near death, with frank pus covering the spinal cord at surgery." | 3.66 | Intravenous metronidazole therapy for Bacteroides fragilis meningitis. ( Bryan, CS; Del Bene, VE; Huffman, LJ; Sanders, CV; Scalcini, MC, 1979) |
| " Adverse events were reported by 9% of patients in the isepamicin group (16/178) and 10% of patients in the amikacin group (9/89)." | 2.68 | The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections. ( Leal del Rosal, P, 1995) |
| "Six of the 72 patients (8." | 2.65 | Prophylactic metronidazole in appendectomy: a double-blind controlled trial. ( Feld, R; Keiser, TA; Leers, N; MacKenzie, RL, 1983) |
| "Bacteremia was infrequently detected, but isolated pathogens were multidrug resistant." | 1.56 | Prevalence, Etiology, and Outcome of Sepsis among Critically Ill Patients in Malawi. ( Charles, A; Kadyaudzu, C; Onofrey, L; Prin, M; Purcell, L, 2020) |
| "Metronidazole is an antiprotozoal antibiotic that serves as a preeminent anaerobic chemotherapeutic agent." | 1.48 | Radiosynthesis and Biodistribution of ( Ahmad, M; Iqbal, A; Mansha, A; Naqvi, SAR; Rasheed, R; Zahoor, AF, 2018) |
| "We present a case of extragenitourinary malakoplakia, developing in a patient with a history of plasma cell myeloma, which clinically mimicked recurrent extramedullary myelomatous involvement." | 1.37 | Extragenitourinary malakoplakia in a patient with myeloma clinically mimicking extramedullary myelomatous disease. ( Cox, RM; El Jamal, SM; Lorsbach, RB; Malak, SF, 2011) |
| "Moxifloxacin has been suggested as an option for monotherapy of intra-abdominal infections." | 1.33 | Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model. ( Hermsen, ED; Hovde, LB; Rodvold, KA; Rotschafer, JC; Sprandel, KA, 2005) |
| "The development of toxic megacolon as a complication of infectious colitis is rare." | 1.33 | Toxic megacolon complicating Escherichia coli O157 infection. ( Koerner, RJ; McElroy, J; Nayar, DM; Pai, P; Vetrivel, S, 2006) |
| " CAT identifies Escherichia coli and Bacteroides fragilis as the most important pathogens for intraabdominal infections and determines the most effective antibiotics at the tissue breakpoint, which is defined as the minimal concentration maintained for more than 90% of the dosage interval period at the infected tissues." | 1.28 | Calculated empiric antimicrobial therapy for mixed surgical infections. ( Bergstein, JM; Frantzides, C; Wittmann, DH, 1991) |
| " This study demonstrated the efficacy of penicillin and clavulanic acid in the treatment of infections caused by Bacteroides fragilis alone or in combination with beta-lactamase-producing aerobic bacteria." | 1.27 | Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria. ( Brook, I; Coolbaugh, JC; Walker, RI, 1983) |
| " fragilis was similar and at all dosage levels a significant correlation was found between the numbers of Bact." | 1.27 | Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice. ( Dijkmans, BA; Hermans, J; Mattie, H; van Furth, R, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (55.74) | 18.7374 |
| 1990's | 6 (9.84) | 18.2507 |
| 2000's | 9 (14.75) | 29.6817 |
| 2010's | 10 (16.39) | 24.3611 |
| 2020's | 2 (3.28) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, WJ | 1 |
| Wu, ZR | 1 |
| Yang, Q | 1 |
| Hu, HJ | 1 |
| Wang, JK | 1 |
| Shi, YJ | 1 |
| Li, FY | 1 |
| Cheng, NS | 1 |
| Prin, M | 1 |
| Onofrey, L | 1 |
| Purcell, L | 1 |
| Kadyaudzu, C | 1 |
| Charles, A | 1 |
| Iqbal, A | 1 |
| Naqvi, SAR | 1 |
| Rasheed, R | 1 |
| Mansha, A | 1 |
| Ahmad, M | 1 |
| Zahoor, AF | 1 |
| Magréault, S | 1 |
| Leroux, S | 1 |
| Touati, J | 1 |
| Storme, T | 1 |
| Jacqz-Aigrain, E | 1 |
| Obinwa, O | 1 |
| Casidy, M | 1 |
| Flynn, J | 1 |
| Popejoy, MW | 1 |
| Paterson, DL | 1 |
| Cloutier, D | 1 |
| Huntington, JA | 1 |
| Miller, B | 1 |
| Bliss, CA | 1 |
| Steenbergen, JN | 1 |
| Hershberger, E | 1 |
| Umeh, O | 1 |
| Kaye, KS | 1 |
| Ayoub, T | 1 |
| Arshad, I | 1 |
| Donnellan, I | 1 |
| Goren, MG | 1 |
| Carmeli, Y | 1 |
| Schwaber, MJ | 1 |
| Chmelnitsky, I | 1 |
| Schechner, V | 1 |
| Navon-Venezia, S | 1 |
| Basiri, A | 1 |
| Javaherforooshzadeh, A | 1 |
| El Jamal, SM | 1 |
| Malak, SF | 1 |
| Cox, RM | 1 |
| Lorsbach, RB | 1 |
| Gupta, P | 1 |
| Gupta, R | 2 |
| Jandial, K | 1 |
| Samotra, S | 1 |
| Rana, V | 1 |
| Gupta, S | 1 |
| Singh, J | 1 |
| Kim, JH | 2 |
| Jung, ES | 1 |
| Jeong, SH | 1 |
| Kim, JS | 1 |
| Ku, YS | 1 |
| Hahm, KB | 1 |
| Kim, YS | 1 |
| Mouaffak, Y | 1 |
| Boutbaoucht, M | 1 |
| Soraa, N | 1 |
| Chabaa, L | 1 |
| Salama, T | 1 |
| Oulad Saiad, M | 1 |
| Younous, S | 1 |
| SZELL, I | 1 |
| EMBER, M | 1 |
| NOVAK, E | 1 |
| DRAPER, JW | 1 |
| AKBARI, A | 1 |
| WARD, JN | 1 |
| Yigitler, C | 1 |
| Gulec, B | 1 |
| Aydogan, H | 1 |
| Ozcan, A | 1 |
| Kilinc, M | 1 |
| Yigit, T | 1 |
| Kozak, O | 1 |
| Pekcan, M | 1 |
| Gosselink, MP | 1 |
| Schouten, WR | 1 |
| van Lieshout, LM | 1 |
| Hop, WC | 1 |
| Laman, JD | 1 |
| Ruseler-van Embden, JG | 1 |
| Hermsen, ED | 1 |
| Hovde, LB | 1 |
| Sprandel, KA | 1 |
| Rodvold, KA | 1 |
| Rotschafer, JC | 1 |
| Serra, T | 1 |
| González de Cárdenas, M | 1 |
| Plovins, J | 1 |
| Ballesteros, A | 1 |
| Vindel, A | 1 |
| Sáez-Nieto, JA | 1 |
| Carey, JC | 1 |
| Klebanoff, MA | 1 |
| Nayar, DM | 1 |
| Vetrivel, S | 1 |
| McElroy, J | 1 |
| Pai, P | 1 |
| Koerner, RJ | 1 |
| Shen, ZJ | 1 |
| Chen, SW | 1 |
| Wang, H | 1 |
| Zhou, XL | 1 |
| Zhao, JP | 1 |
| Peltola, V | 1 |
| Svedström, E | 1 |
| Waris, M | 1 |
| Heikkinen, T | 1 |
| Ruuskanen, O | 1 |
| Jones, GR | 1 |
| Keiser, TA | 1 |
| MacKenzie, RL | 1 |
| Feld, R | 1 |
| Leers, N | 1 |
| Lau, WY | 1 |
| Fan, ST | 1 |
| Yiu, TF | 1 |
| Wong, SH | 1 |
| Reznikov, M | 2 |
| McDonald, PJ | 1 |
| Brook, I | 4 |
| Coolbaugh, JC | 1 |
| Walker, RI | 2 |
| Dijkmans, BA | 1 |
| Mattie, H | 1 |
| Hermans, J | 1 |
| van Furth, R | 1 |
| Ralph, ED | 1 |
| Gorbach, SL | 1 |
| Vacca, A | 1 |
| Henderson, A | 1 |
| Lewis, RT | 1 |
| Allan, CM | 1 |
| Goodall, RG | 1 |
| Lloyd-Smith, WC | 1 |
| Marien, B | 1 |
| Park, M | 1 |
| Wiegand, FM | 1 |
| Rylander, M | 1 |
| Holm, SE | 1 |
| Brorson, JE | 1 |
| Johnsson, J | 1 |
| Norrby, R | 1 |
| Sazhin, VP | 1 |
| Korovin, AIa | 1 |
| Sorokin, VM | 1 |
| Sypchenko, AIa | 1 |
| Van der Auwera, P | 1 |
| Collier, J | 1 |
| Goris, RJ | 1 |
| Saario, I | 1 |
| Willis, AT | 1 |
| Collazo, E | 1 |
| Luna, M | 1 |
| Bibi, M | 1 |
| Megdiche, H | 1 |
| Ghanem, H | 1 |
| Sfaxi, I | 1 |
| Nouira, M | 1 |
| Essaidi, H | 1 |
| Chaieb, A | 1 |
| Slama, A | 1 |
| Khairi, H | 1 |
| Ledney, GD | 1 |
| Leal del Rosal, P | 1 |
| Eichenwald, HF | 1 |
| Goulton, J | 1 |
| Wilkinson, MA | 1 |
| Baker, PG | 1 |
| Onderdonk, AB | 1 |
| Louie, TJ | 1 |
| Tally, FP | 1 |
| Bartlett, JG | 1 |
| Bryan, CS | 1 |
| Huffman, LJ | 1 |
| Del Bene, VE | 1 |
| Sanders, CV | 1 |
| Scalcini, MC | 1 |
| Donta, ST | 1 |
| Salem, AR | 1 |
| Jackson, DD | 1 |
| McFadzean, JA | 1 |
| Wittmann, DH | 1 |
| Bergstein, JM | 1 |
| Frantzides, C | 1 |
| Duel, P | 1 |
| Siboni, K | 1 |
| Jensen, TG | 1 |
| Smith, GR | 1 |
| Wallace, LM | 1 |
| Till, D | 1 |
| Beale, AS | 2 |
| Gisby, J | 2 |
| Porteous, C | 1 |
| Davidson, PM | 1 |
| Rawluk, D | 1 |
| Brown, M | 1 |
| Scott, R | 1 |
| Conn, G | 1 |
| McClure, A | 1 |
| Murray, WR | 1 |
| Muhvich, KH | 1 |
| Myers, RA | 1 |
| Marzella, L | 1 |
| Sutherland, R | 1 |
| Wijma, J | 1 |
| Kauer, FM | 1 |
| van Saene, HK | 1 |
| van de Wiel, HB | 1 |
| Janssens, J | 1 |
| Sleptsov, VP | 1 |
| Astakhov, AA | 1 |
| Slezkin, GA | 1 |
| Kharchenko, DM | 1 |
| Hakendorf, PH | 1 |
| Matthews, DB | 1 |
| Kling, PA | 1 |
| Holmlund, D | 1 |
| Burman, LG | 1 |
| Heiss, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis[NCT00583531] | Phase 2 | 2 participants (Actual) | Interventional | 2007-03-31 | Terminated (stopped due to Lack of enrollment) | ||
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis[NCT00583076] | Phase 2 | 19 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for metronidazole and Escherichia coli Infections
| Article | Year |
|---|---|
Current experience with clindamycin in the treatment of abdominal and female pelvic infections.
Topics: Abdomen; Animals; Bacterial Infections; Bacteroides Infections; Clindamycin; Clinical Trials as Topi | 1984 |
14 trials available for metronidazole and Escherichia coli Infections
| Article | Year |
|---|---|
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urin | 2017 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Prophylactic metronidazole in appendectomy: a double-blind controlled trial.
Topics: Adolescent; Adult; Appendectomy; Bacteroides fragilis; Bacteroides Infections; Double-Blind Method; | 1983 |
Prophylaxis of post-appendicectomy sepsis by metronidazole and ampicillin: a randomized, prospective and double-blind trial.
Topics: Ampicillin; Appendectomy; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Clinic | 1983 |
Current experience with clindamycin in the treatment of abdominal and female pelvic infections.
Topics: Abdomen; Animals; Bacterial Infections; Bacteroides Infections; Clindamycin; Clinical Trials as Topi | 1984 |
Preventing anaerobic infection in surgery of the colon.
Topics: Administration, Oral; Aged; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides I | 1981 |
A comparison of metronidazole and clindamycin for the treatment of intra-abdominal anaerobic infection: a multicentre trial.
Topics: Abdomen; Adolescent; Adult; Aged; Anaerobiosis; Bacterial Infections; Bacteroides fragilis; Bacteroi | 1982 |
Obeid's technique for treatment of pilonidal sinus.
Topics: Adult; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Male; Metronidazole; Pilonidal Si | 1994 |
[Antibiotic prophylaxis in a priori cesarean sections without a high risk of infection. Experiences of a Tunisian maternity department].
Topics: Adult; Anti-Bacterial Agents; Cephapirin; Cesarean Section; Drug Costs; Escherichia coli Infections; | 1994 |
The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cholecystitis; Drug Administration Schedule; Escherichia col | 1995 |
Peri-incisional mezlocillin versus rectal-metronidazole for wound infection prophylaxis.
Topics: Adolescent; Adult; Appendectomy; Bacteroides fragilis; Bacteroides Infections; Child; Clinical Trial | 1985 |
Antibiotics and suction drainage as prophylaxis in vaginal and abdominal hysterectomy.
Topics: Abscess; Bacteroides Infections; Cefuroxime; Cephalosporins; Cystitis; Escherichia coli Infections; | 1987 |
Prevention of post-operative infection in appendicectomy by single dose intravenous metronidazole. An open prospective randomised study.
Topics: Adolescent; Adult; Aged; Appendectomy; Appendicitis; Child; Doxycycline; Escherichia coli Infections | 1985 |
[Clinical evaluation of medicines active against trichomoniasis vaginalis in a double-blind study].
Topics: Adolescent; Adult; Age Factors; Antiprotozoal Agents; Candidiasis, Vulvovaginal; Child; Clinical Tri | 1971 |
47 other studies available for metronidazole and Escherichia coli Infections
| Article | Year |
|---|---|
Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Chlorhexidine; Cholangitis; Chronic Disease; Collagen Ty | 2020 |
Prevalence, Etiology, and Outcome of Sepsis among Critically Ill Patients in Malawi.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Burkholderia Infections; Candida glabra | 2020 |
Radiosynthesis and Biodistribution of
Topics: Animals; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Metronidazole; Rabbi | 2018 |
UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Blood Chemical Analysis; Calibration; | 2019 |
The microbiology of bacterial peritonitis due to appendicitis in children.
Topics: Adolescent; Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; A | 2014 |
Concurrent emphysematous cholecystitis and emphysematous cystitis in a non-diabetic patient.
Topics: Aged, 80 and over; Anti-Infective Agents; Cefuroxime; Cystitis; Drug Therapy, Combination; Emphysema | 2009 |
Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colisti | 2010 |
Percutaneous drainage for treatment of prostate abscess.
Topics: Abscess; Aged; Ceftazidime; Cystostomy; Drainage; Escherichia coli; Escherichia coli Infections; Hum | 2010 |
Extragenitourinary malakoplakia in a patient with myeloma clinically mimicking extramedullary myelomatous disease.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Escherichia coli Infections; Humans; Malacopl | 2011 |
Emphysematous pyelonephritis in the setting of diabetes mellitus.
Topics: Anti-Infective Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Emphysema; Escherichia co | 2011 |
A case of emphysematous hepatitis with spontaneous pneumoperitoneum in a patient with hilar cholangiocarcinoma.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cefotaxime; | 2012 |
[Bacteriology of community-acquired peritonitis in children treated in the university hospital of Marrakech].
Topics: Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cephalosporins; Child; Child, Preschool; Community | 2013 |
[TREATMENT OF TRICHOMONAL VAGINITIS WITH IMIDAZOLE DERIVATE].
Topics: Chloramphenicol; Cystitis; Escherichia coli Infections; Female; Humans; Imidazoles; Metronidazole; N | 1963 |
THERAPEUTIC PROBLEMS IN URINARY INFECTIONS.
Topics: Chloramphenicol; Enterobacter aerogenes; Escherichia coli Infections; Humans; Hydrocortisone; Imidaz | 1964 |
Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Translocation; Co | 2004 |
Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Chromatography, | 2005 |
[Three cases of Yersinia pseudotuberculosis gastrointestinal infection having no apparent epidemiological relationship, caused by identical strains].
Topics: Abdominal Pain; Adult; Amoxicillin; Bacterial Typing Techniques; Child; Diarrhea; Doxycycline; Drug | 2005 |
Is a change in the vaginal flora associated with an increased risk of preterm birth?
Topics: Administration, Intravaginal; Adult; Case-Control Studies; Cohort Studies; Confidence Intervals; Esc | 2005 |
Toxic megacolon complicating Escherichia coli O157 infection.
Topics: Adult; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Colitis; Colon; Escherichia coli | 2006 |
Life-threatening meningitis resulting from transrectal prostate biopsy.
Topics: Adenocarcinoma; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Biopsy; Escherichia col | 2005 |
Pulmonary abscess of viral-bacterial etiology in a neonate.
Topics: Anti-Infective Agents; Cefuroxime; Cephalexin; Escherichia coli Infections; Female; Humans; Infant, | 2007 |
Bacterial synergy in mixed aerobic/anaerobic infections.
Topics: Aerobiosis; Anaerobiosis; Animals; Bacteria; Bacteroides Infections; Escherichia coli Infections; Gu | 1980 |
Bacterial synergy in mixed aerobic/anaerobic infections.
Topics: Bacteroides fragilis; Bacteroides Infections; Escherichia coli; Escherichia coli Infections; Humans; | 1980 |
Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
Topics: Abscess; Animals; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; Escherichia coli Infe | 1983 |
Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacteroides Infections; Clavulanic Acid; Clavulanic Acids; | 1983 |
Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; Dose-Response Relationship, Drug; Drug Resist | 1984 |
Successful antimicrobial therapy of hepatic, intra-abdominal and intrapelvic abscesses.
Topics: Abdomen; Abscess; Adult; Aged; Anti-Bacterial Agents; Escherichia coli Infections; Female; Fusobacte | 1984 |
Puerperal sepsis in Port Moresby, Papua New Guinea.
Topics: Bacteroides Infections; Chloramphenicol; Escherichia coli Infections; Female; Humans; Metronidazole; | 1980 |
Activity of metronidazole on Bacteroides fragilis and/or Escherichia coli in vitro and in vivo.
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; Dose-Response Relationship, Drug; Escherichia | 1981 |
[Metronidazole in prevention and treatment of wound infection].
Topics: Escherichia coli Infections; Gastrointestinal Diseases; Humans; Metronidazole; Surgical Wound Infect | 1981 |
The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Topics: Abscess; Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Drug Resistance | 1994 |
[Diarrhea. Diagnostic and therapeutic data].
Topics: Anti-Bacterial Agents; Diarrhea; Entamoebiasis; Escherichia coli Infections; Humans; Metronidazole; | 1977 |
Multicentre study of 'Flagyl' in the prevention of post-operative anaerobic infection.
Topics: Aged; Bacterial Infections; Bacteroides Infections; Child; Digestive System Surgical Procedures; Esc | 1979 |
Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis.
Topics: Animals; Bacillus; Bacterial Infections; Cecum; Escherichia coli Infections; Male; Metronidazole; Mi | 1979 |
Intravenous metronidazole therapy for Bacteroides fragilis meningitis.
Topics: Adult; Aged; Bacteroides fragilis; Bacteroides Infections; Chloramphenicol; Drug Therapy, Combinatio | 1979 |
Changing concepts of infectious diarrheas.
Topics: Acute Disease; Aged; Amebiasis; Anti-Bacterial Agents; Bacterial Infections; Clostridium Infections; | 1975 |
An investigation of interactions between metronidazole ("Flagl") and other antibacterial agents.
Topics: Aerobiosis; Anaerobiosis; Animals; Anti-Infective Agents; Drug Interactions; Escherichia coli Infect | 1975 |
Calculated empiric antimicrobial therapy for mixed surgical infections.
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; | 1991 |
Intracranial abscesses in Odense Hospital. Survey of bacteriology, epidemiology, and treatment with antibiotics, 1963-1989.
Topics: Adolescent; Adult; Aged; Ampicillin; Bacteroides Infections; Brain Abscess; Cefotaxime; Child; Child | 1991 |
Necrobacillosis and immunity in mice.
Topics: Animals; Escherichia coli; Escherichia coli Infections; Fusobacterium; Fusobacterium Infections; Imm | 1989 |
Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
Topics: Amoxicillin; Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefotaxime; Cef | 1989 |
Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
Topics: Abscess; Aerobiosis; Anaerobiosis; Animals; Bacteroides; Bacteroides fragilis; Bacteroides Infection | 1988 |
The relationship between Fusobacterium species and other flora in mixed infection.
Topics: Abscess; Animals; Bacteroides Infections; Escherichia coli Infections; Fusobacterium; Fusobacterium | 1986 |
Effect of hyperbaric oxygenation, combined with antimicrobial agents and surgery, in a rat model of intraabdominal infection.
Topics: Abdomen; Abscess; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Dise | 1988 |
Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agen | 1988 |
[Metronidazole in the complex treatment of peritonitis of appendicular etiology in children].
Topics: Appendicitis; Bacteroides fragilis; Bacteroides Infections; Child; Combined Modality Therapy; Escher | 1987 |
Response of a 'susceptible' Escherichia coli to metronidazole therapy: an investigation using experimental subcutaneous abscesses.
Topics: Abscess; Animals; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Escheric | 1985 |